SEARCH

SEARCH BY CITATION

References

  • Ashley EA, Krudsood S, Phaiphun L et al. (2004) Dose optimization randomized controlled studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multi-drug resistant falciparum malaria in Thailand. Journal of Infectious Diseases 190, 17731782.
  • Ashley EA, McGready R, Hutagalung R et al. (2005) A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clinical Infectious Diseases 41, 425432.
  • Brockman A, Paul RE, Anderson TJ et al. (1999) Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. American Journal of Tropical Medicine and Hygiene 60, 1421.
  • Ter Kuile FO, Luxemburger C, Nosten F, Thwai KL, Chongsuphajaisiddhi T & White NJ (1995) Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 660664.
  • Luxemburger C, Thwai KL, White NJ et al. (1996) The epidemiology of malaria in a Karen population on the western border of Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 105111.
  • NCI (1999) Common Toxicity Criteria, Ver. 2.0. National Cancer Institute, Bethesda, MD.
  • Nosten F, Van Vugt M, Price R et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297302.
  • White N (2003) Malaria. In: Manson's Tropical Diseases, 21st edn (ed. GCAZumla) W.B. Saunders, Edinburgh, pp. 12051296.
  • WHO (2006) Guidelines for the Treatment of Malaria. World Health Organization, Geneva.